Neuropathic pain and geriatric assessment in people 80 and older
Evaluation of the Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older
This project will find how common neuropathic pain is in people aged 80 and older and see if it links to results of a detailed geriatric assessment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 450 (estimated) |
| Ages | 80 Years and up |
| Sex | All |
| Sponsor | Sultan 1. Murat State Hospital Government |
| Locations | 1 site (Edirne) |
| Trial ID | NCT07487610 on ClinicalTrials.gov |
What this trial studies
Researchers will enroll patients aged 80 years or older at Sultan 1. Murat State Hospital and perform a comprehensive geriatric assessment along with screening for neuropathic pain. The study is observational and collects clinical, functional, and cognitive parameters to determine the frequency of neuropathic pain in the oldest-old. Patients with moderate-to-severe dementia, recent acute illness, psychotic disorder, severe hearing loss, or a history of malignancy are excluded. The aim is to identify correlations between neuropathic pain presence and specific geriatric assessment measures.
Who should consider this trial
Good fit: Ideal candidates are people aged 80 or older who can fully cooperate and complete a comprehensive geriatric assessment and who do not have moderate-to-severe dementia, recent acute illness, psychosis, severe hearing loss, or a history of cancer.
Not a fit: Patients with CDR-2 or CDR-3 dementia, recent acute illness, psychotic disorders, severe hearing loss, a history of malignancy, or those unable to cooperate are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the results could help clinicians recognize neuropathic pain in the oldest-old and tailor management based on geriatric assessment findings.
How similar studies have performed: Previous observational work has documented neuropathic pain in older adults, but studies focused specifically on people aged 80 and above are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 80 years or older * Full cooperation * Complete comprehensive geriatric assessment parameters Exclusion Criteria: * Patients with dementia classified as CDR-2 or CDR-3 according to the Clinical Dementia Rating (CDR) Scale * Patients who have experienced an acute illness within the last 1 month (e.g., infection, fracture, or cerebrovascular disease) * Patients with a psychotic disorder * Patients with severe hearing loss * Patients with a history of malignancy
Where this trial is running
Edirne
- Sultan 1. Murat State Hospital — Edirne, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Kübra Altunkalem Seydi, MD — Sultan 1. Murat State Hospital
- Study coordinator: Alper Mengi, MD
- Email: dralpmengi@gmail.com
- Phone: +90 537 651 03 85
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.